Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for ANDA 072691

Expand all

AMOXAPINE (AMOXAPINE)
25MG
Marketing Status: Prescription

Active Ingredient: AMOXAPINE
Proprietary Name: AMOXAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A072691
Product Number: 002
Approval Date: Aug 28, 1992
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

AMOXAPINE (AMOXAPINE)
50MG
Marketing Status: Prescription

Active Ingredient: AMOXAPINE
Proprietary Name: AMOXAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 50MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A072691
Product Number: 003
Approval Date: Aug 28, 1992
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

AMOXAPINE (AMOXAPINE)
100MG
Marketing Status: Prescription

Active Ingredient: AMOXAPINE
Proprietary Name: AMOXAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 100MG
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: A072691
Product Number: 004
Approval Date: Aug 28, 1992
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information

AMOXAPINE (AMOXAPINE)
150MG
Marketing Status: Prescription

Active Ingredient: AMOXAPINE
Proprietary Name: AMOXAPINE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 150MG
Reference Listed Drug: No
Reference Standard: Yes
TE Code: 
Application Number: A072691
Product Number: 001
Approval Date: Aug 28, 1992
Applicant Holder Full Name: WATSON LABORATORIES INC
Marketing Status:  Prescription
Patent and Exclusivity Information